A Multiple Dose Study to Assess the Safety, Tolerability and PK of Risperidone Extended Release Capsules
Clinical trial NCT04567524 · COMPLETED
Trial details
- NCT number
- NCT04567524
- Sponsor
- Lyndra Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-13
- Primary completion
- 2020-12-22
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.